Search results

…icines, or another condition. Follow up a deficiency with a plan tailored to the exact test rather than using someone else’s combination of results.

…ports an exposure-related condition and which alternative explanations have been assessed. Discuss the limitations of proposed biomarkers and how the plan will track meaningful changes in health.

…and other findings explain the kidney problem. A nephrology plan should guide medicines, supplement safety, and monitoring; common genetic findings do not predict an inevitable loss of kidney function.

… should be reviewed alongside the established bowel-disease plan.

…inician about testing, exposure avoidance, and an emergency plan appropriate to your reactions. A cytokine result cannot establish whether a particular food or medicine is safe for you.

…eyond dryness. Review supplements alongside medicines and a plan for protecting eyes, teeth, and other affected organs.

…alth conditions, and previous treatment response affect the plan. A common genetic variant is different from a confirmed diagnosis of psoriasis.

…rbation history affect treatment. Continue an asthma action plan and review any supplements with the prescribing clinician.

… ask about genetic counseling and the appropriate screening plan.

…tatus, and bone-density testing fit together. A bone-health plan should consider fracture risk and established osteoporosis care as well as nutrition.

…n, endoscopy, or infection testing is appropriate. The care plan should address the confirmed cause rather than an isolated cytokine or genetic finding.

… antioxidant strategy fits with your cystic fibrosis team’s plan. It should not replace airway clearance, infection treatment, or appropriate CFTR therapy.